Premier Biomedical, Inc. (BIEI)
| Market Cap | 1.30M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -202,173 |
| Shares Out | 999.98M |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 336,440 |
| Open | 0.0015 |
| Previous Close | 0.0016 |
| Day's Range | n/a |
| 52-Week Range | 0.0005 - 0.0017 |
| Beta | -4.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BIEI
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology
Premier, N/K/A Nova-Graphene Ballistics, Inc., has Acquired the Rights to Use, Within the United States, this Proprietary Technology for Lightweight, Extremely Protective, Graphene Ballistic Plate Pro...